HemaCare Corporation, a leading provider in the biotechnology sector, is headquartered in the United States and operates extensively across North America. Founded in 1978, HemaCare has established itself as a pivotal player in the field of human cellular products, specialising in the collection, processing, and distribution of blood components and cellular therapies. The company’s core offerings include a range of high-quality leukapheresis products and customised cell processing services, which are distinguished by their commitment to quality and regulatory compliance. HemaCare's innovative approach has positioned it as a trusted partner for research institutions and pharmaceutical companies, contributing significantly to advancements in regenerative medicine and immunotherapy. With a strong market presence and a reputation for excellence, HemaCare continues to drive progress in the biotechnology landscape.
We don't have data for HemaCare Corporation, but we can show you information about their parent organization instead.
View parent company